Edition:
United Kingdom

Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

6.12USD
22 Feb 2019
Change (% chg)

$-0.06 (-0.97%)
Prev Close
$6.18
Open
$6.12
Day's High
$6.12
Day's Low
$6.12
Volume
402
Avg. Vol
4,391
52-wk High
$10.57
52-wk Low
$3.66

Chart for

About

Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)

Overall

Beta: --
Market Cap(Mil.): $168.94
Shares Outstanding(Mil.): 13.88
Dividend: --
Yield (%): --

Financials

  ALPN.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -6.42 -- --
ROI: -48.40 8.92 14.45
ROE: -48.40 10.08 15.96

Earnings vs. Estimates